InvestorsHub Logo
Followers 11
Posts 344
Boards Moderated 0
Alias Born 02/01/2011

Re: CaptBeer post# 336423

Thursday, 04/22/2021 1:01:20 PM

Thursday, April 22, 2021 1:01:20 PM

Post# of 426025
Ahoi Capt'n! Did you consider asking about including any questions on the progress of VASCEPA for COVID19 treatment options?

I am sorry if that was already discussed here, but I just got back and have no ability to read up on the last thousands of entries here..
I wish that COVID could be impressed on their mindset as a priority issue and not on the backburner as they do need to move on this in a timely fashion.

https://www.uspharmacist.com/article/icosapent-ethyl-linked-to-decreased-inflammation-and-improved-covid19-symptoms

There are other therapies out there based on human hormones that have astounding efficacy and are already included by Dr. Fauci in direct comparative trials with REMDESIVIR under auspices of the NIH:

https://www.nih.gov/news-events/news-releases/clinical-trial-therapeutics-severely-ill-hospitalized-covid-19-patients-begins#.YIGCIeEERSU.twitter

By the time AMRN is moving on this , the new drug AVIPTADIL // ZYESAMI by RLFTF might already be standard of care replacing REMDESIVIR...

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News